source
- Mirador Therapeutics announces partnership to acquire Kira drug, positioning it against TavneosMirador Therapeutics, a San Diego‑based biotech focused on immune diseases and backed by more than $650 million in venture capital, has disclosed a new element of its development pipeline. The com…
- Republicans block bill to end Medicare AI prior-authorization pilotA Senate vote on Thursday failed to halt a Medicare pilot that uses artificial intelligence to approve or deny care. The measure, backed by Democrats, was rejected by a 46‑to‑50 vote, with Republic…